Quercetin‐Driven Akkermansia Muciniphila Alleviates Obesity by Modulating Bile Acid Metabolism via an ILA/m 6 A/CYP8B1 Signaling
Advanced Science · 2025-03 · 12 (12)
DOI: 10.1002/advs.202412865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 31.01.2025. Verfasst von Jiaqi Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Sciences, Zhejiang University, Hangzhou, 310058, China. Hauptthemen laut MEDLINE: Quercetin, Obesity, Bile Acids and Salts, Steroid 12-alpha-Hydroxylase. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Innovation Leading Talent project of Zhejiang Province, NIEHS NIH HHS.
Abstract (Originalsprache)
Global health is increasingly challenged by the growing prevalence of obesity and its associated complications. Quercetin, one of the most important dietary flavonoids, is being explored as an effective therapy for obesity with its mechanism remains understudied. Here in this study, it is demonstrated that quercetin intervention significantly reverses obesity‐related phenotypes through reshaping the overall structure of microbiota, especially boosting colonization of the beneficial gut commensal Akkermansia muciniphila ( A. muciniphila ). Enrichment of A. muciniphila leads to generate more indole‐3‐lactic acid (ILA) to upregulate the expression of 12α‐hydroxylase (CYP8B1) via fat mass and obesity‐associated protein (FTO)/ N 6 ‐methyladenosine (m 6 A)/YTHDF2 manner, thereby facilitating cholesterol converts to cholic acid (CA). CA in turn drastically suppresses lipid accumulation via activating the farnesoid X receptor (FXR) in adipose tissue. This work introduces a novel therapeutic target for addressing obesity and expands upon the current limited understanding of the mediator function of m 6 A modifications in microorganism‐influenced bile acid (BA) metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Sciences, Zhejiang University, Hangzhou, 310058, China.
- Key Laboratory of Molecular Animal Nutrition (Zhejiang University), Ministry of Education, Hangzhou, 3100058, China.
- Key Laboratory of Animal Nutrition and Feed Science (Eastern of China), Ministry of Agriculture and Rural Affairs, Hangzhou, 310058, China.
- Zhejiang Key Laboratory of Nutrition and Breeding for High-quality Animal Products, Hangzhou, 310058, China.
- Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, Howard Hughes Medical Institute, The University of Chicago, 929 East 57th Street, Chicago, IL, 60637, USA.
ORCID-Profile: Xinxia Wang
Förderung
- National Natural Science Foundation of China
- Science and Technology Innovation Leading Talent project of Zhejiang Province
- NIEHS NIH HHS
- National Key R&D Program of China
- Zhejiang University Global Partnership Fund
- National Key Research and Development Program of China
Zitieren
APA
Liu, J., Liu, Y., Huang, C., He, C., Yang, T., Ren, R., Xin, Z., & Wang, X. (2025). Quercetin‐Driven Akkermansia Muciniphila Alleviates Obesity by Modulating Bile Acid Metabolism via an ILA/m 6 A/CYP8B1 Signaling. Advanced Science, 12(12). https://doi.org/10.1002/advs.202412865
Vancouver
Liu J, Liu Y, Huang C, He C, Yang T, Ren R, et al. Quercetin‐Driven Akkermansia Muciniphila Alleviates Obesity by Modulating Bile Acid Metabolism via an ILA/m 6 A/CYP8B1 Signaling. Advanced Science. 2025;12(12). doi:10.1002/advs.202412865
BibTeX
@article{Liu2025,
author = {Liu, Jiaqi and Liu, Youhua and Huang, Chaoqun and He, Chuan and Yang, Tongyudan and Ren, Ruiti and Xin, Zimeng and Wang, Xinxia},
title = {Quercetin‐Driven Akkermansia Muciniphila Alleviates Obesity by Modulating Bile Acid Metabolism via an ILA/m 6 A/CYP8B1 Signaling},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {12},
doi = {10.1002/advs.202412865}
}
EUVIMED